Chief Operating Officer · Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Craig Millian

A named executive officer of Corbus Pharmaceuticals in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$1,826,009

Salary $414,000Stock awards $0Bonus $128,000

FY2020: $1,250,709

4th of 4 named executive officers at Corbus Pharmaceuticals by FY2021 total.

4 named officers on file for Corbus Pharmaceuticals, FY2021

Craig Millian’s pay file — $29

  • 2 fiscal years of pay, line by line
  • CRBP’s disclosed peer group of 1 company

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Corbus Pharmaceuticals’s whole pay program stands against its peers

  • Corbus Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CRBP→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 1, 2022 (DEF 14A).

Free

Get Craig Millian’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Craig Millian compensation by year

Corbus Pharmaceuticals Summary Compensation Table · all 2 fiscal years held
In US dollars, as Corbus Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$400,000$414,000
Bonus$128,000$128,000
Stock awards$0$0
Option awards$722,709$1,284,009
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$1,250,709$1,826,009

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Corbus Pharmaceuticals Holdings, Inc. DEF 14A filed April 1, 2022, accession 0000950170-22-005263, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Corbus Pharmaceuticals Holdings, Inc. filed document, accession 0000950170-22-005263. Every figure is read from that document and cited to the page and table it appears in. Filed April 1, 2022.

$1.3M
$1.8M
FY20
FY21
SalaryBonusOption awards

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option52,500—$6.94
Option127,125—$4.53
Option614,600—$2.58

Per the Outstanding Equity Awards at Fiscal Year-End table in Corbus Pharmaceuticals Holdings, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Corbus Pharmaceuticals’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Yuval CohenChief Executive Officer$4,843,519
Barbara WhiteChief Medical Officer$1,878,889
Sean MoranChief Financial Officer$1,826,009
Craig Millian · this pageChief Operating Officer$1,826,009

The full Corbus Pharmaceuticals compensation record

free company brief

This page is one person within Corbus Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Corbus Pharmaceuticals proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Corbus Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Craig Millian's compensation dossier · One-time report. No refunds.